Hofseth BioCare ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	254.43	256.83	190.82	119.13	76.88
Other Revenue	1.91	8.71	27.7	1.32	10.74
Revenue	256.34	265.54	218.51	120.45	87.62
Revenue Growth (YoY)	-3.46%	21.52%	81.42%	37.47%	26.52%
Cost of Revenue	160.97	189.81	165	102.49	77.05
Gross Profit	95.37	75.73	53.51	17.96	10.57
Selling, General & Admin	81.7	91.37	76.25	76.03	60.35
Other Operating Expenses	86.61	49.66	43.38	40.13	39.43
Operating Expenses	207.72	180.81	156.04	146.39	129.13
Operating Income	-112.35	-105.08	-102.53	-128.43	-118.56
Interest Expense	-22.83	-15.69	-7.54	-9.95	-9.39
Interest & Investment Income	2	0.79	0.55	0.65	0.61
Earnings From Equity Investments	2.15	-7.48	2.54	-0.2	0.03
Currency Exchange Gain (Loss)	-3.68	2.16	0.3	0.74	0.91
Other Non Operating Income (Expenses)	-	-	-0	-	-0.06
EBT Excluding Unusual Items	-134.71	-125.3	-106.69	-137.2	-126.46
Asset Writedown	-	-	-	-0.19	-
Pretax Income	-134.71	-125.3	-106.69	-137.39	-126.46
Income Tax Expense	0.18	-	-	-	-
Earnings From Continuing Operations	-134.88	-125.3	-106.69	-137.39	-126.46
Minority Interest in Earnings	0	0	0	0	0
Net Income	-134.88	-125.3	-106.68	-137.39	-126.46
Net Income to Common	-134.88	-125.3	-106.68	-137.39	-126.46
Shares Outstanding (Basic)	411	411	395	375	358
Shares Outstanding (Diluted)	411	411	395	375	358
Shares Change (YoY)	0.04%	4.01%	5.43%	4.72%	7.25%
EPS (Basic)	-0.33	-0.30	-0.27	-0.37	-0.35
EPS (Diluted)	-0.33	-0.30	-0.27	-0.37	-0.35
Free Cash Flow	-40.92	-12.22	-5.43	-49.19	-84.7
Free Cash Flow Per Share	-0.10	-0.03	-0.01	-0.13	-0.24
Gross Margin	37.21%	28.52%	24.49%	14.91%	12.06%
Operating Margin	-43.83%	-39.57%	-46.92%	-106.63%	-135.32%
Profit Margin	-52.62%	-47.19%	-48.82%	-114.06%	-144.34%
Free Cash Flow Margin	-15.96%	-4.60%	-2.49%	-40.84%	-96.67%
EBITDA	-72.93	-90.71	-89.83	-118.46	-104.57
EBITDA Margin	-28.45%	-34.16%	-41.11%	-98.35%	-119.35%
D&A For EBITDA	39.41	14.37	12.7	9.97	14
EBIT	-112.35	-105.08	-102.53	-128.43	-118.56
EBIT Margin	-43.83%	-39.57%	-46.92%	-106.63%	-135.32%
Revenue as Reported	256.34	265.54	218.51	120.45	87.62
Advertising Expenses	-	15.33	13.49	15.04	13.03

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.